NantKwest (NK) Priced

Developing cancer immunotherapies based on natural killer cells.

Health Care - Biotechnology

IPO Performance
Latest Trade $5.12 0.00 (0.0%)
First Day Return 38.6%
Return from IPO -79.5%
 
NantKwest IPO News more
  • .
IPO Data
IPO File Date 06/19/2015
Offer Price $25.00
Price Range $20.00 - $23.00
Offer Shares (mm) 8.3
Deal Size ($mm) 207
 
IPO Data
IPO Date 07/27/2015
Offer Price $25.00
Price Range $20.00 - $23.00
Offer Shares (mm) 8.3
Deal Size ($mm) $207
 
Underwriters
more
Business Overview
Developing cancer immunotherapies based on natural killer cells.
Developing cancer immunotherapies based on natural killer cells.
more
Company Data
Headquarters Cardiff-by-the-Sea, CA
Founded 2002
Employees 15
Website www.nantkwest.com
 

Performance vs. IPO Index (IPOUSA)